Deals

Yifan Pharmaceutical Signs Exclusive Commercialization Agreement With Eisai for Halaven in Mainland China – Originator Anti-Tumor Drug Strengthens Oncology Portfolio
CancerEisai

Yifan Pharmaceutical Signs Exclusive Commercialization Agreement With Eisai for Halaven in Mainland China – Originator Anti-Tumor Drug Strengthens Oncology Portfolio

Yifan Pharmaceutical (SHE: 002019) announced that it has officially signed a commercialization agreement with Eisai Co., Ltd. (TYO: 4523). Under the terms, Yifan Pharmaceutical will obtain exclusive rights to import,…

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline

Siemens Healthineers and NVIDIA Partner to Develop Next-Generation Adaptive Radiotherapy Technology – Combining Agentic and Robotic Intelligence With Accelerated Computing

Siemens Healthineers and NVIDIA Partner to Develop Next-Generation Adaptive Radiotherapy Technology – Combining Agentic and Robotic Intelligence With Accelerated Computing

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone
BioRay Pharmaceutical

Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone

Eisai Transfers Pariet Rights in China to CBC Group-Controlled Peak Pharma
Anbison LabC&O Pharmaceutical Technology

Eisai Transfers Pariet Rights in China to CBC Group-Controlled Peak Pharma

Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy
Alcon LaboratoriesAurion Biotech

Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy

TransThera and Akeso Biopharma Collaborate on HCC Study with Tinengotinib and Bispecific Antibodies
Akeso BiopharmaClinical trial approval / initiation

TransThera and Akeso Biopharma Collaborate on HCC Study with Tinengotinib and Bispecific Antibodies

Show More